CSIMarket



Best Performing Stocks In Healthcare Sector During The Last 5 Days



 1 Day   Week  Current Month of June  30 Days 
Current Quarter Q2 of 2024  90 Days    Ytd    12 Months 
 

Shares fell by -0.17% on average, in Healthcare Sector during the last 5 days.

Here are the best performing stocks in Healthcare Sector.




LGVN

$3.19

$2.1300 200.94%
Last 5 Days


LGVN

$3.19

$2.1300 200.94%



Longeveron Inc

Longeveron Inc shares improved 200.94% during the last 5 days.


Longeveron Inc*s business model involves the development and commercialization of regenerative medicine products using mesenchymal stem cells for various medical conditions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 6.756 mill. $ 0.800 mill. $ -20.231 mill. 2 mill. - Y/Y -43.40 %
Market Cap. Revenues TTM Net Income TTM

$ 6.756 mill.


$ 0.800 mill.


$ -20.231 mill.

Employees Shares Outstanding P/E

-


2 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -43.40 %


MRQ Y/Y - %



BRTX

$1.85

$0.6800 58.12%
Last 5 Days


BRTX

$1.85

$0.6800 58.12%



Biorestorative Therapies Inc

Biorestorative Therapies Inc stock went up 58.12% during the last 5 days.


Biorestorative Therapies Inc (BRTX) is a biotechnology company that focuses on developing and commercializing regenerative therapies using cell and tissue protocols. Their business model entails researching, acquiring, and licensing new technologies and proprietary stem cell techniques, which are utilized to develop therapeutic products for various medical conditions. BRTX aims to collaborate with research institutions, healthcare providers, and industry partners to advance the field of regenerative medicine and bring novel treatments to patients.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 7.798 mill. $ 0.121 mill. $ -14.107 mill. 4 mill. - Y/Y -27.59 %
Market Cap. Revenues TTM Net Income TTM

$ 7.798 mill.


$ 0.121 mill.


$ -14.107 mill.

Employees Shares Outstanding P/E

-


4 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -27.59 %


MRQ Y/Y - %



GTHP

$0.14

$0.0500 55.56%
Last 5 Days


GTHP

$0.14

$0.0500 55.56%



Guided Therapeutics Inc

Guided Therapeutics Inc stock went up 55.56% during the last 5 days.


Guided Therapeutics Inc operates on a business model focused on developing and commercializing medical devices for the early detection and monitoring of diseases, with a particular emphasis on cervical cancer.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 7.665 mill. $ 0.082 mill. $ -3.056 mill. 55 mill. - Y/Y -72.73 %
Market Cap. Revenues TTM Net Income TTM

$ 7.665 mill.


$ 0.082 mill.


$ -3.056 mill.

Employees Shares Outstanding P/E

-


55 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -72.73 %


MRQ Y/Y - %



MOLN

$6.77

$2.3700 53.86%
Last 5 Days


MOLN

$6.77

$2.3700 53.86%



Molecular Partners Ag

Molecular Partners Ag shares increased 53.86% during the last 5 days.


Molecular Partners Ag is a biotechnology company that operates on an innovative business model focused on the development of therapeutic drugs. The company utilizes its proprietary DARPin technology platform to create a pipeline of potential treatments for various diseases. Molecular Partners Ag primarily collaborates with strategic partners, including pharmaceutical companies, to advance its drug candidates through preclinical and clinical development stages.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 221.857 mill. $ 7.038 mill. $ -61.984 mill. 33 mill. - Y/Y -96.29 %
Market Cap. Revenues TTM Net Income TTM

$ 221.857 mill.


$ 7.038 mill.


$ -61.984 mill.

Employees Shares Outstanding P/E

-


33 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -96.29 %


MRQ Y/Y - %



URGN

$19.2

$6.4300 50.35%
Last 5 Days


URGN

$19.2

$6.4300 50.35%



Urogen Pharma Ltd

Urogen Pharma Ltd shares went up 50.35% during the last 5 days.


Urogen Pharma Ltd is a pharmaceutical company that specializes in developing and commercializing innovative therapies for urological and oncological conditions. Their business model revolves around conducting extensive research and development to create novel therapies, obtaining necessary regulatory approvals, and strategically partnering with healthcare providers and other stakeholders to market and distribute their products globally. By focusing on addressing unmet medical needs in the urology field, Urogen Pharma aims to improve patient outcomes and establish a strong presence in the market.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 640.892 mill. $ 83.213 mill. $ -104.317 mill. 33 mill. - Y/Y 5.01 %
Market Cap. Revenues TTM Net Income TTM

$ 640.892 mill.


$ 83.213 mill.


$ -104.317 mill.

Employees Shares Outstanding P/E

-


33 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 5.01 %


MRQ Y/Y - %



RNA

$39.64

$12.5300 46.22%
Last 5 Days


RNA

$39.64

$12.5300 46.22%



Avidity Biosciences Inc

Avidity Biosciences Inc shares went up 46.22% during the last 5 days.


Avidity Biosciences Inc*s business model revolves around developing and commercializing potential therapeutics using its proprietary AOC platform, which enables the targeted delivery of drugs to specific cells in the body.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3,457.084 mill. $ 10.870 mill. $ -228.681 mill. 87 mill. - Y/Y 58.67 %
Market Cap. Revenues TTM Net Income TTM

$ 3,457.084 mill.


$ 10.870 mill.


$ -228.681 mill.

Employees Shares Outstanding P/E

-


87 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 58.67 %


MRQ Y/Y - %



SCLX

$1.61

$0.4900 43.75%
Last 5 Days


SCLX

$1.61

$0.4900 43.75%



Scilex Holding Company

Scilex Holding Company shares improved 43.75% during the last 5 days.


Scilex Holding Company operates as a pharmaceutical company focused on the development and commercialization of prescription drugs. Through its business model, it aims to identify and acquire assets that have the potential to address unmet medical needs and improve patient outcomes. The company primarily focuses on developing innovative, differentiated products in the therapeutic areas of pain management and neurology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 225.091 mill. $ 71.315 mill. $ -116.919 mill. 140 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 225.091 mill.


$ 71.315 mill.


$ -116.919 mill.

Employees Shares Outstanding P/E

-


140 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



NXL

$0.8992

$0.2392 36.24%
Last 5 Days


NXL

$0.8992

$0.2392 36.24%



Nexalin Technology Inc

Nexalin Technology Inc stock went up 36.24% during the last 5 days.


Nexalin Technology Inc is a company that operates on a business model centered around providing innovative neuromodulation therapies. Their approach involves utilizing proprietary technology to offer non-invasive treatment options for mental health disorders such as depression, anxiety, and addiction. By delivering safe and effective solutions, Nexalin aims to improve the quality of life for their patients, revolutionizing the field of neuromodulation.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 6.687 mill. $ -1,754.532 mill. $ -4.508 mill. 7 mill. - Y/Y -28.96 %
Market Cap. Revenues TTM Net Income TTM

$ 6.687 mill.


$ -1,754.532 mill.


$ -4.508 mill.

Employees Shares Outstanding P/E

-


7 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -28.96 %


MRQ Y/Y - %



INVO

$1.03

$0.2700 35.53%
Last 5 Days


INVO

$1.03

$0.2700 35.53%



Invo Bioscience Inc

Invo Bioscience Inc stock went up 35.53% during the last 5 days.


Invo Bioscience Inc operates on a business model focused on developing and commercializing advanced medical devices in the field of reproductive health. Their flagship product, INVOcell, is a novel fertility treatment that allows fertilization and early embryo development to occur within the woman*s body. This innovative approach provides a more affordable and accessible option for couples seeking assisted reproductive technology.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3.916 mill. $ 4.249 mill. $ -7.080 mill. 4 mill. - Y/Y 352.92 %
Market Cap. Revenues TTM Net Income TTM

$ 3.916 mill.


$ 4.249 mill.


$ -7.080 mill.

Employees Shares Outstanding P/E

-


4 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 352.92 %


MRQ Y/Y - %



ISPC

$0.5

$0.1300 35.14%
Last 5 Days


ISPC

$0.5

$0.1300 35.14%



Ispecimen inc

Ispecimen Inc stock went up 35.14% during the last 5 days.


iSpecimen Inc*s business model revolves around connecting researchers with the biospecimens they need for their scientific and medical studies. They serve as an intermediary platform that links healthcare organizations and biobanks to the research community, providing a streamlined process for sourcing human biosamples and associated data.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 4.566 mill. $ 9.268 mill. $ -11.570 mill. 9 mill. - Y/Y -22.38 %
Market Cap. Revenues TTM Net Income TTM

$ 4.566 mill.


$ 9.268 mill.


$ -11.570 mill.

Employees Shares Outstanding P/E

-


9 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -22.38 %


MRQ Y/Y - %



NUVO

$1.67

$0.4200 33.60%
Last 5 Days


NUVO

$1.67

$0.4200 33.60%



Holdco Nuvo Group D g Ltd

Holdco Nuvo Group D G Ltd stock increased 33.60% during the last 5 days.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ - mill. $ 0.176 mill. $ 0.000 mill. - mill. - Y/Y 0.00 %
Market Cap. Revenues TTM Net Income TTM

$ - mill.


$ 0.176 mill.


$ 0.000 mill.

Employees Shares Outstanding P/E

-


- mill.


-

Revenue Growth Income Growth

MRQ Y/Y 0.00 %


MRQ Y/Y - %



CANF

$3.35

$0.8200 32.41%
Last 5 Days


CANF

$3.35

$0.8200 32.41%



Can fite Biopharma Ltd

Can Fite Biopharma Ltd shares increased 32.41% during the last 5 days.


Can-Fite Biopharma Ltd is a pharmaceutical company that focuses on developing and commercializing drugs for the treatment of inflammatory diseases and cancer.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2,732.750 mill. $ 0.810 mill. $ -10.173 mill. 816 mill. - Y/Y -5.04 %
Market Cap. Revenues TTM Net Income TTM

$ 2,732.750 mill.


$ 0.810 mill.


$ -10.173 mill.

Employees Shares Outstanding P/E

-


816 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -5.04 %


MRQ Y/Y - %



ELOX

$0.8

$0.1939 31.99%
Last 5 Days


ELOX

$0.8

$0.1939 31.99%



Eloxx Pharmaceuticals Inc

Eloxx Pharmaceuticals Inc stock went up 31.99% during the last 5 days.


Eloxx Pharmaceuticals Inc operates as a biopharmaceutical company focused on the discovery and development of novel therapies for genetic diseases. Their business model involves leveraging their expertise in RNA modulation to develop and commercialize therapeutic candidates that can potentially restore protein functionality in genetic disorders.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2.198 mill. $ - mill. $ -32.102 mill. 3 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 2.198 mill.


$ - mill.


$ -32.102 mill.

Employees Shares Outstanding P/E

-


3 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



BMEA

$5.64

$1.3300 30.86%
Last 5 Days


BMEA

$5.64

$1.3300 30.86%



Biomea Fusion Inc

Biomea Fusion Inc stock improved 30.86% during the last 5 days.


Biomea Fusion Inc operates on a business model focused on the development of precision medicine for cancer treatments. They leverage advanced genomic technologies to identify and understand specific gene fusions that drive cancer growth. By developing targeted therapies, they aim to improve patient outcomes and revolutionize cancer treatment.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 201.088 mill. $ - mill. $ -107.685 mill. 36 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 201.088 mill.


$ - mill.


$ -107.685 mill.

Employees Shares Outstanding P/E

33


36 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



LWLG

$3.51

$0.7900 29.04%
Last 5 Days


LWLG

$3.51

$0.7900 29.04%



Lightwave Logic Inc

Lightwave Logic Inc shares increased 29.04% during the last 5 days.


Lightwave Logic Inc*s business model is focused on developing and commercializing advanced photonic devices and technologies for various industries.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 417.517 mill. $ 0.030 mill. $ -21.778 mill. 119 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 417.517 mill.


$ 0.030 mill.


$ -21.778 mill.

Employees Shares Outstanding P/E

10


119 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



KPRX

$5.36

$1.2020 28.91%
Last 5 Days


KPRX

$5.36

$1.2020 28.91%



Kiora Pharmaceuticals Inc

Kiora Pharmaceuticals Inc stock increased 28.91% during the last 5 days.


Kiora Pharmaceuticals Inc operates with a business model focused on the research, development, and commercialization of innovative pharmaceutical products for various medical conditions and diseases. The company aims to create value through the discovery of new drugs, rigorous clinical trials, and strategic partnerships for ultimate patient benefit and sustainable growth.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 187.737 mill. $ 16.000 mill. $ 2.808 mill. 35 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 187.737 mill.


$ 16.000 mill.


$ 2.808 mill.

Employees Shares Outstanding P/E

-


35 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



TSOI

$0.0009

$0.0002 28.57%
Last 5 Days


TSOI

$0.0009

$0.0002 28.57%



Therapeutic Solutions International Inc

Therapeutic Solutions International Inc shares increased 28.57% during the last 5 days.


Therapeutic Solutions International Inc is a company that operates under a business model focused on researching, developing, and commercializing cutting-edge treatments and therapies for various medical conditions. Their approach involves identifying innovative technologies and products, conducting rigorous scientific research, and partnering with healthcare professionals and organizations to bring their solutions to the market. Through their business model, they aim to improve patient outcomes and revolutionize medical treatments across different fields.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2.852 mill. $ - mill. $ -3.742 mill. 3,169 mill. 1.76 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 2.852 mill.


$ - mill.


$ -3.742 mill.

Employees Shares Outstanding P/E

-


3,169 mill.


1.76

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



ORGS

$0.5798

$0.1198 26.04%
Last 5 Days


ORGS

$0.5798

$0.1198 26.04%



Orgenesis Inc

Orgenesis Inc shares improved 26.04% during the last 5 days.


Orgenesis Inc operates under a business model focused on the development and commercialization of technologies related to cell and gene therapies. They collaborate with academic institutions and hospitals to identify potential therapies, and then use their expertise in advanced manufacturing and cell therapy technologies to scale production and develop clinical protocols. Through partnerships and licensing agreements, Orgenesis aims to bring these innovative therapies to market and improve the lives of patients with chronic diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 19.236 mill. $ -43,181.636 mill. $ 62.218 mill. 33 mill. 0.38 Y/Y -0.70 %
Market Cap. Revenues TTM Net Income TTM

$ 19.236 mill.


$ -43,181.636 mill.


$ 62.218 mill.

Employees Shares Outstanding P/E

111


33 mill.


0.38

Revenue Growth Income Growth

MRQ Y/Y -0.70 %


MRQ Y/Y -57.20 %



AKTX

$3.16

$0.6400 25.40%
Last 5 Days


AKTX

$3.16

$0.6400 25.40%



Akari Therapeutics Plc

Akari Therapeutics Plc shares went up 25.40% during the last 5 days.


Akari Therapeutics Plc is a biopharmaceutical company that develops and commercializes treatments for autoimmune and inflammatory diseases. Their business model revolves around conducting research, clinical trials, and obtaining regulatory approvals for their product candidates. They aim to provide innovative therapies to patients and generate revenue through the sale and licensing of their products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 986.467 mill. $ - mill. $ -17.748 mill. 312 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 986.467 mill.


$ - mill.


$ -17.748 mill.

Employees Shares Outstanding P/E

15


312 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



STSS

$0.3443

$0.0692 25.15%
Last 5 Days


STSS

$0.3443

$0.0692 25.15%



Sharps Technology Inc

Sharps Technology Inc shares went up 25.15% during the last 5 days.


Sharps Technology Inc operates as a technology solutions provider, offering a range of products and services to businesses in various industries. Their business model is focused on developing and delivering innovative technological solutions tailored to meet their clients* specific needs and requirements. By leveraging their expertise, they aim to help businesses enhance efficiency, productivity, and overall performance through the implementation of cutting-edge technological solutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 6.423 mill. $ - mill. $ 5.527 mill. 19 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 6.423 mill.


$ - mill.


$ 5.527 mill.

Employees Shares Outstanding P/E

-


19 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



ODYY

$0.0488

$0.0098 25.13%
Last 5 Days


ODYY

$0.0488

$0.0098 25.13%



Odyssey Health Inc

Odyssey Health Inc stock went up 25.13% during the last 5 days.


Odyssey Health Inc is a healthcare organization that employs a subscription-based business model. The company provides comprehensive medical services to its members for a monthly fee, offering personalized healthcare solutions and a range of preventative care services. Through this model, Odyssey Health aims to ensure accessible and affordable healthcare for individuals and families.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 5.065 mill. $ - mill. $ 11.020 mill. 104 mill. 0.54 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 5.065 mill.


$ - mill.


$ 11.020 mill.

Employees Shares Outstanding P/E

-


104 mill.


0.54

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



TNGX

$8.93

$1.7700 24.72%
Last 5 Days


TNGX

$8.93

$1.7700 24.72%



Tango Therapeutics Inc

Tango Therapeutics Inc shares went up 24.72% during the last 5 days.


Tango Therapeutics Inc is a biotechnology company that focuses on developing cancer therapies using DNA sequencing and computational biology. Their business model revolves around discovering and developing precision medicines by leveraging their expertise in genomics and biology to target specific cancer vulnerabilities.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 866.507 mill. $ 37.507 mill. $ -100.041 mill. 97 mill. - Y/Y 55.09 %
Market Cap. Revenues TTM Net Income TTM

$ 866.507 mill.


$ 37.507 mill.


$ -100.041 mill.

Employees Shares Outstanding P/E

-


97 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 55.09 %


MRQ Y/Y - %



DHAI

$2.74

$0.5400 24.55%
Last 5 Days


DHAI

$2.74

$0.5400 24.55%



Dih Holding Us Inc

Dih Holding Us Inc stock improved 24.55% during the last 5 days.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 35.083 mill. $ - mill. $ 0.640 mill. 13 mill. 44.35 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 35.083 mill.


$ - mill.


$ 0.640 mill.

Employees Shares Outstanding P/E

-


13 mill.


44.35

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y -71.50 %



AMRN

$0.7781

$0.1501 23.90%
Last 5 Days


AMRN

$0.7781

$0.1501 23.90%



Amarin Corp Plcuk

Amarin Corp Plcuk shares went up 23.90% during the last 5 days.


Amarin Corp Plcuk*s business model revolves around the development, commercialization, and marketing of innovative pharmaceutical products, particularly focused on cardiovascular health.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 317.789 mill. $ 279.993 mill. $ -52.475 mill. 408 mill. - Y/Y 5.09 %
Market Cap. Revenues TTM Net Income TTM

$ 317.789 mill.


$ 279.993 mill.


$ -52.475 mill.

Employees Shares Outstanding P/E

1,040


408 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 5.09 %


MRQ Y/Y - %



AEMD

$0.693

$0.1325 23.64%
Last 5 Days


AEMD

$0.693

$0.1325 23.64%



Aethlon Medical Inc

Aethlon Medical Inc shares went up 23.64% during the last 5 days.


Aethlon Medical Inc*s business model revolves around the development and commercialization of innovative therapeutic devices designed to address life-threatening conditions. The company aims to create and market medical solutions that target the removal of disease-causing particles from the circulatory system, with a focus on infectious diseases and cancer.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ - mill. $ - mill. $ -12.630 mill. - mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ - mill.


$ - mill.


$ -12.630 mill.

Employees Shares Outstanding P/E

-


- mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



MREO

$4.25

$0.7800 22.48%
Last 5 Days


MREO

$4.25

$0.7800 22.48%



Mereo Biopharma Group Plc

Mereo Biopharma Group Plc stock went up 22.48% during the last 5 days.


Mereo Biopharma Group Plc*s business model focuses on the development and commercialization of innovative therapeutics for rare diseases.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2,422.217 mill. $ - mill. $ -34.196 mill. 570 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 2,422.217 mill.


$ - mill.


$ -34.196 mill.

Employees Shares Outstanding P/E

46


570 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



TRIB

$2.78

$0.5000 21.93%
Last 5 Days


TRIB

$2.78

$0.5000 21.93%



Trinity Biotech Plc

Trinity Biotech Plc shares improved 21.93% during the last 5 days.


Trinity Biotech Plc*s business model is focused on developing, manufacturing, and marketing diagnostic products for clinical laboratories and point-of-care testing.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 21.264 mill. $ 56.832 mill. $ -36.868 mill. 8 mill. - Y/Y -24.00 %
Market Cap. Revenues TTM Net Income TTM

$ 21.264 mill.


$ 56.832 mill.


$ -36.868 mill.

Employees Shares Outstanding P/E

569


8 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -24.00 %


MRQ Y/Y - %



SCNI

$3.49

$0.6262 21.87%
Last 5 Days


SCNI

$3.49

$0.6262 21.87%



Scinai Immunotherapeutics Ltd

Scinai Immunotherapeutics Ltd shares increased 21.87% during the last 5 days.





Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 545.357 mill. $ - mill. $ 6.500 mill. 156 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 545.357 mill.


$ - mill.


$ 6.500 mill.

Employees Shares Outstanding P/E

-


156 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y 0.00 %



SQZB

$0.045

$0.0080 21.62%
Last 5 Days


SQZB

$0.045

$0.0080 21.62%



Sqz Biotechnologies Company

Sqz Biotechnologies Company stock increased 21.62% during the last 5 days.


Sqz Biotechnologies Company*s business model revolves around developing and commercializing innovative cell engineering platforms for multiple applications across the healthcare industry.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 1.327 mill. $ - mill. $ 0.000 mill. 29 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 1.327 mill.


$ - mill.


$ 0.000 mill.

Employees Shares Outstanding P/E

-


29 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



MNPR

$0.94

$0.1654 21.35%
Last 5 Days


MNPR

$0.94

$0.1654 21.35%



Monopar Therapeutics Inc

Monopar Therapeutics Inc stock went up 21.35% during the last 5 days.


Monopar Therapeutics Inc operates under a business model focused on developing and commercializing innovative therapeutics for the treatment of various cancers. The company aims to leverage strategic partnerships with academic institutions and other pharmaceutical companies to facilitate the development and distribution of their products.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 15.021 mill. $ - mill. $ -7.609 mill. 16 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 15.021 mill.


$ - mill.


$ -7.609 mill.

Employees Shares Outstanding P/E

-


16 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



DNTH

$26

$4.5350 21.13%
Last 5 Days


DNTH

$26

$4.5350 21.13%



Dianthus Therapeutics Inc

Dianthus Therapeutics Inc stock increased 21.13% during the last 5 days.


Dianthus Therapeutics Inc is a biotechnology company that focuses on developing novel genetic medicines for patients suffering from rare genetic diseases. Their business model revolves around leveraging cutting-edge gene therapy technologies to design and deliver innovative treatments. By partnering with academic institutions and utilizing a proprietary gene therapy platform, they aim to address unmet medical needs and provide potential new therapies for patients with genetic disorders.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 101.579 mill. $ 0.924 mill. $ -67.395 mill. 4 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 101.579 mill.


$ 0.924 mill.


$ -67.395 mill.

Employees Shares Outstanding P/E

-


4 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



AXIM

$0.0082

$0.0014 20.59%
Last 5 Days


AXIM

$0.0082

$0.0014 20.59%



Axim Biotechnologies Inc

Axim Biotechnologies Inc stock went up 20.59% during the last 5 days.


Axim Biotechnologies Inc*s business model revolves around developing and commercializing innovative pharmaceutical and nutraceutical products, primarily focusing on cannabinoid-based therapies.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 2.397 mill. $ 0.085 mill. $ -5.589 mill. 292 mill. - Y/Y 616.22 %
Market Cap. Revenues TTM Net Income TTM

$ 2.397 mill.


$ 0.085 mill.


$ -5.589 mill.

Employees Shares Outstanding P/E

-


292 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 616.22 %


MRQ Y/Y - %



MRKR

$4.1647

$0.6947 20.02%
Last 5 Days


MRKR

$4.1647

$0.6947 20.02%



Marker Therapeutics inc

Marker Therapeutics Inc stock improved 20.02% during the last 5 days.


Marker Therapeutics Inc is a biotechnology company that aims to develop and commercialize novel T cell immunotherapies for the treatment of cancer. Their business model focuses on leveraging their expertise in cellular engineering to develop proprietary technologies and therapies that can be licensed or partnered with other organizations for further development and commercialization.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 37.074 mill. $ -0.179 mill. $ -5.662 mill. 9 mill. - Y/Y -73.72 %
Market Cap. Revenues TTM Net Income TTM

$ 37.074 mill.


$ -0.179 mill.


$ -5.662 mill.

Employees Shares Outstanding P/E

-


9 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -73.72 %


MRQ Y/Y - %



CYCN

$2.7156

$0.4489 19.80%
Last 5 Days


CYCN

$2.7156

$0.4489 19.80%



Cyclerion Therapeutics Inc

Cyclerion Therapeutics Inc stock improved 19.80% during the last 5 days.


Cyclerion Therapeutics Inc*s business model focuses on developing and commercializing innovative therapies for serious and chronic diseases by targeting soluble guanylate cyclase (sGC).


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 7.566 mill. $ - mill. $ -17.100 mill. 3 mill. 1.26 Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 7.566 mill.


$ - mill.


$ -17.100 mill.

Employees Shares Outstanding P/E

-


3 mill.


1.26

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



VRNA

$15.14

$2.4900 19.68%
Last 5 Days


VRNA

$15.14

$2.4900 19.68%



Verona Pharma Plc

Verona Pharma Plc shares increased 19.68% during the last 5 days.


Verona Pharma Plc is a biopharmaceutical company that focuses on developing and commercializing innovative therapies for respiratory diseases. Their business model revolves around discovering and advancing new drug candidates, conducting clinical trials, and ultimately bringing these potential treatments to market. By leveraging their expertise in respiratory medicine, they aim to address unmet medical needs and improve the lives of patients suffering from respiratory conditions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 9,775.913 mill. $ - mill. $ -63.420 mill. 646 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 9,775.913 mill.


$ - mill.


$ -63.420 mill.

Employees Shares Outstanding P/E

64


646 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



CODX

$1.59

$0.2600 19.55%
Last 5 Days


CODX

$1.59

$0.2600 19.55%



Co diagnostics Inc

Co Diagnostics Inc stock improved 19.55% during the last 5 days.


Co Diagnostics Inc is a biotech company that follows a business-to-business (B2B) model. They develop and manufacture molecular diagnostics for various infectious diseases. Their revenue is generated by selling these diagnostics directly to healthcare organizations, laboratories, and research institutions.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 46.816 mill. $ 6.627 mill. $ -35.333 mill. 29 mill. - Y/Y 140.48 %
Market Cap. Revenues TTM Net Income TTM

$ 46.816 mill.


$ 6.627 mill.


$ -35.333 mill.

Employees Shares Outstanding P/E

-


29 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 140.48 %


MRQ Y/Y - %



COEP

$0.329

$0.0530 19.20%
Last 5 Days


COEP

$0.329

$0.0530 19.20%



Coeptis Therapeutics Holdings Inc

Coeptis Therapeutics Holdings Inc shares increased 19.20% during the last 5 days.


Coeptis Therapeutics Holdings Inc. is a pharmaceutical company that focuses on the development and commercialization of innovative therapies. Their business model involves researching, formulating, and manufacturing drugs to address unmet medical needs in various therapeutic areas. They aim to bring these treatments to market to improve patient outcomes and generate revenue through sales and licensing agreements.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 11.694 mill. $ - mill. $ -16.579 mill. 36 mill. - Y/Y - %
Market Cap. Revenues TTM Net Income TTM

$ 11.694 mill.


$ - mill.


$ -16.579 mill.

Employees Shares Outstanding P/E

-


36 mill.


-

Revenue Growth Income Growth

MRQ Y/Y - %


MRQ Y/Y - %



AVRW

$0.0539

$0.0086 18.98%
Last 5 Days


AVRW

$0.0539

$0.0086 18.98%



Avenir Wellness Solutions Inc

Avenir Wellness Solutions Inc stock went up 18.98% during the last 5 days.


Avenir Wellness Solutions Inc is a health and wellness company that operates through a subscription-based model. They offer personalized wellness programs, incorporating nutrition, fitness, and mental health, to their members. With a focus on providing comprehensive and tailored services, Avenir Wellness Solutions Inc aims to promote overall well-being and help individuals achieve their health goals.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 3.490 mill. $ 4.575 mill. $ -4.530 mill. 65 mill. - Y/Y -89.88 %
Market Cap. Revenues TTM Net Income TTM

$ 3.490 mill.


$ 4.575 mill.


$ -4.530 mill.

Employees Shares Outstanding P/E

-


65 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -89.88 %


MRQ Y/Y - %



LPCN

$9.49

$1.5100 18.92%
Last 5 Days


LPCN

$9.49

$1.5100 18.92%



Lipocine Inc

Lipocine Inc stock improved 18.92% during the last 5 days.


Lipocine Inc is a pharmaceutical company focused on developing oral drug delivery systems for hormone therapeutics. Their business model involves conducting research and development to create innovative products that address unmet medical needs in areas such as testosterone replacement therapy and hypogonadism. The company aims to commercialize these proprietary drug candidates and collaborate with industry partners to enhance their potential reach and impact.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 49.679 mill. $ -2.851 mill. $ -16.352 mill. 5 mill. - Y/Y 164.58 %
Market Cap. Revenues TTM Net Income TTM

$ 49.679 mill.


$ -2.851 mill.


$ -16.352 mill.

Employees Shares Outstanding P/E

-


5 mill.


-

Revenue Growth Income Growth

MRQ Y/Y 164.58 %


MRQ Y/Y - %



SNGX

$4.06

$0.6300 18.37%
Last 5 Days


SNGX

$4.06

$0.6300 18.37%



Soligenix inc

Soligenix Inc stock went up 18.37% during the last 5 days.


Soligenix Inc. is a biopharmaceutical company that focuses on developing and commercializing products to treat rare diseases. Their business model revolves around leveraging their expertise in developing innovative therapies and securing partnerships and collaborations with academic institutions, government agencies, and other companies to accelerate the development process. Soligenix also strategically seeks funding through grants and licensing deals to support their pipeline and growth initiatives.


Market Cap. Revenues TTM Net Income TTM Shares Outstanding P/E Revenue Growth
$ 42.716 mill. $ 0.699 mill. $ -7.010 mill. 11 mill. - Y/Y -54.49 %
Market Cap. Revenues TTM Net Income TTM

$ 42.716 mill.


$ 0.699 mill.


$ -7.010 mill.

Employees Shares Outstanding P/E

-


11 mill.


-

Revenue Growth Income Growth

MRQ Y/Y -54.49 %


MRQ Y/Y - %




 1 Day   Week  Current Month of June  30 Days 
Current Quarter Q2 of 2024  90 Days    Ytd    12 Months 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com